Total Return Level Chart

Historical Total Return Level Data

View and export this data back to 2015. Start Trial.
Date Value
November 17, 2026 271.19
November 16, 2026 271.73
November 13, 2026 275.39
November 12, 2026 267.07
November 11, 2026 259.28
November 10, 2026 256.59
November 09, 2026 259.85
November 06, 2026 256.82
November 05, 2026 253.45
November 04, 2026 257.93
November 03, 2026 250.17
November 02, 2026 248.98
October 30, 2026 251.27
October 29, 2026 253.00
October 28, 2026 249.55
October 27, 2026 245.85
October 26, 2026 245.15
October 23, 2026 243.37
October 22, 2026 242.99
October 21, 2026 238.90
October 20, 2026 234.33
October 19, 2026 229.95
October 16, 2026 225.25
October 15, 2026 226.62
October 14, 2026 227.00
Date Value
October 13, 2026 223.21
October 12, 2026 227.00
October 09, 2026 229.23
October 08, 2026 222.69
October 07, 2026 228.41
October 06, 2026 226.05
October 05, 2026 228.03
October 02, 2026 227.87
October 01, 2026 227.31
September 30, 2026 227.83
September 29, 2026 228.07
September 28, 2026 230.05
September 25, 2026 225.60
September 24, 2026 230.70
September 23, 2026 223.13
September 22, 2026 237.57
September 21, 2026 237.59
September 18, 2026 236.72
September 17, 2026 239.04
September 16, 2026 247.69
September 15, 2026 239.77
September 14, 2026 264.92
September 11, 2026 263.52
September 10, 2026 261.23
September 09, 2026 260.81

Total Return Level Definition

The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.

Read full definition.

Total Return Level Range, Past 5 Years

View Total Return Level Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Return Level Benchmarks

View Total Return Level Benchmarks
Start Trial
BioMarin Pharmaceutical, Inc. 58.51
Novo Nordisk A/S 72.83
Genmab A/S 51.96
Zealand Pharma A/S 35.93
Evaxion AS 2.78